435 related articles for article (PubMed ID: 25680287)
41. Mutations of Bruton's tyrosine kinase gene in Brazilian patients with X-linked agammaglobulinemia.
Ramalho VD; Oliveira Júnior EB; Tani SM; Roxo Júnior P; Vilela MM
Braz J Med Biol Res; 2010 Sep; 43(9):910-3. PubMed ID: 20721470
[TBL] [Abstract][Full Text] [Related]
42. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
[TBL] [Abstract][Full Text] [Related]
43. Genotype-phenotype correlation in Bruton's tyrosine kinase deficiency.
Teimourian S; Nasseri S; Pouladi N; Yeganeh M; Aghamohammadi A
J Pediatr Hematol Oncol; 2008 Sep; 30(9):679-83. PubMed ID: 18776760
[TBL] [Abstract][Full Text] [Related]
44. In vitro correction of a novel splicing alteration in the BTK gene by using antisense morpholino oligonucleotides.
Rattanachartnarong N; Tongkobpetch S; Chatchatee P; Daengsuwan T; Ittiwut C; Suphapeetiporn K; Shotelersuk V
Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):431-6. PubMed ID: 24658450
[TBL] [Abstract][Full Text] [Related]
45. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
[TBL] [Abstract][Full Text] [Related]
46. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
[TBL] [Abstract][Full Text] [Related]
47. Debilitating progressive encephalitis in a patient with BTK deficiency.
Mohammadzadeh I; Yeganeh M; Khaledi M; Salehiomran MR; Aghamohammadi A; Rezaei N
Acta Microbiol Immunol Hung; 2012 Sep; 59(3):335-42. PubMed ID: 22982637
[TBL] [Abstract][Full Text] [Related]
48. A case of X-linked agammaglobulinemia diagnosed in adulthood.
Stewart DM; Tian L; Nelson DL
Clin Immunol; 2001 Apr; 99(1):94-9. PubMed ID: 11286545
[TBL] [Abstract][Full Text] [Related]
49. Maternal germinal mosaicism of X-linked agammaglobulinemia.
Sakamoto M; Kanegane H; Fujii H; Tsukada S; Miyawaki T; Shinomiya N
Am J Med Genet; 2001 Mar; 99(3):234-7. PubMed ID: 11241495
[TBL] [Abstract][Full Text] [Related]
50. A novel Bruton's tyrosine kinase gene (BTK) missense mutation in a Chinese family with X-linked agammaglobulinemia.
Zheng B; Zhang Y; Jin Y; Yu H
BMC Pediatr; 2014 Oct; 14():265. PubMed ID: 25316352
[TBL] [Abstract][Full Text] [Related]
51. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
52. Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.
Yip KL; Chan SY; Ip WK; Lau YL
Hum Mutat; 2000 Apr; 15(4):385. PubMed ID: 10737994
[TBL] [Abstract][Full Text] [Related]
53. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
Pérez de Diego R; López-Granados E; Pozo M; Rodríguez C; Sabina P; Ferreira A; Fontan G; García-Rodríguez MC; Alemany S
J Allergy Clin Immunol; 2006 Jun; 117(6):1462-9. PubMed ID: 16751014
[TBL] [Abstract][Full Text] [Related]
54. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia.
Conley ME; Howard V
J Pediatr; 2002 Oct; 141(4):566-71. PubMed ID: 12378199
[TBL] [Abstract][Full Text] [Related]
55. Transient myelodysplastic syndrome in X-linked agammaglobulinemia with a novel Btk mutation.
Narula G; Currimbhoy Z
Pediatr Blood Cancer; 2008 Dec; 51(6):826-8. PubMed ID: 18726917
[TBL] [Abstract][Full Text] [Related]
56. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
57. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
[TBL] [Abstract][Full Text] [Related]
58. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
[TBL] [Abstract][Full Text] [Related]
59. A Novel
Han SP; Lin YF; Weng HY; Tsai SF; Fu LS
Front Immunol; 2019; 10():1953. PubMed ID: 31481959
[TBL] [Abstract][Full Text] [Related]
60. A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase.
Mesci L; Ozdag H; Turul T; Ersoy F; Tezcan I; Sanal O
Turk J Pediatr; 2006; 48(4):362-4. PubMed ID: 17290574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
